Molecular imaging could find abnormalities at the cellular and molecular levels in the living state during the disease process, conduct qualitative and quantitative research on biological behavior. The occurrence, development and prognosis of tumors were explored through molecular imaging, and the efficacy of targeted drugs was evaluated. It has been widely used in the diagnosis and differential diagnosis of various tumors, organ function research and new drug development. PET tumor imaging uses substances necessary for life metabolisms such as glucose, protein, and nucleic acid to be labeled with short-lifespans radionuclides to reflect the metabolic activities of the tissue, so as to achieve the purpose of diagnosis. Others such as SPECT, MRI, optical bioluminescence/fluorescence, ultrasound, and other emerging ones have also played various roles in tumor diagnosis. This Research Topic will publish rigorously peer-reviewed research advancing our knowledge of the application of molecular imaging in targeted therapeutics of malignant tumors, nuclear oncology, the development of new tumor targeting radiopharmaceuticals, and cancer prevention and management. We would like to provide scientific guidance for malignant tumor diagnosis, treatment, efficacy evaluation, recurrence monitoring, and new drug research and development, further explore the occurrence and development of tumors, and build a bridge between basic research and clinical application.
We welcome submissions focusing on clinical tumor molecular imaging, the new development of novel tumor molecular imaging probes, radiopharmaceutical targeted therapy, and image-guided therapy, including but not limited to:
• Tumor microenvironment, tumor biology and immunology related to malignancy and metastasis
• Nuclear oncology/PET-CT and PET-MRI
• Molecular imaging associated with malignancy and metastasis
• Radionuclide targeted therapy for malignant tumors and metastases
• Development of new tumor targeting radiopharmaceuticals for imaging and therapy
• Epidemiology, cancer prevention, and cancer control associated with malignancy and metastasis
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Molecular imaging could find abnormalities at the cellular and molecular levels in the living state during the disease process, conduct qualitative and quantitative research on biological behavior. The occurrence, development and prognosis of tumors were explored through molecular imaging, and the efficacy of targeted drugs was evaluated. It has been widely used in the diagnosis and differential diagnosis of various tumors, organ function research and new drug development. PET tumor imaging uses substances necessary for life metabolisms such as glucose, protein, and nucleic acid to be labeled with short-lifespans radionuclides to reflect the metabolic activities of the tissue, so as to achieve the purpose of diagnosis. Others such as SPECT, MRI, optical bioluminescence/fluorescence, ultrasound, and other emerging ones have also played various roles in tumor diagnosis. This Research Topic will publish rigorously peer-reviewed research advancing our knowledge of the application of molecular imaging in targeted therapeutics of malignant tumors, nuclear oncology, the development of new tumor targeting radiopharmaceuticals, and cancer prevention and management. We would like to provide scientific guidance for malignant tumor diagnosis, treatment, efficacy evaluation, recurrence monitoring, and new drug research and development, further explore the occurrence and development of tumors, and build a bridge between basic research and clinical application.
We welcome submissions focusing on clinical tumor molecular imaging, the new development of novel tumor molecular imaging probes, radiopharmaceutical targeted therapy, and image-guided therapy, including but not limited to:
• Tumor microenvironment, tumor biology and immunology related to malignancy and metastasis
• Nuclear oncology/PET-CT and PET-MRI
• Molecular imaging associated with malignancy and metastasis
• Radionuclide targeted therapy for malignant tumors and metastases
• Development of new tumor targeting radiopharmaceuticals for imaging and therapy
• Epidemiology, cancer prevention, and cancer control associated with malignancy and metastasis
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
